|
DOCK7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47180000023661E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.08460000045352E-07 |
| Normal-vs-Stage2 |
1.756760E-04 |
| Normal-vs-Stage3 |
2.083600E-03 |
| Normal-vs-Stage4 |
5.881700E-02 |
| Stage1-vs-Stage2 |
7.642000E-01 |
| Stage1-vs-Stage3 |
9.454400E-01 |
| Stage1-vs-Stage4 |
9.538200E-01 |
| Stage2-vs-Stage3 |
7.611400E-01 |
| Stage2-vs-Stage4 |
7.997000E-01 |
| Stage3-vs-Stage4 |
9.909000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.09409999632982E-08 |
| Normal-vs-AfricanAmerican |
1.523520E-03 |
| Normal-vs-Asian |
5.182600E-03 |
| Caucasian-vs-AfricanAmerican |
3.339800E-01 |
| Caucasian-vs-Asian |
9.427200E-01 |
| AfricanAmerican-vs-Asian |
7.033200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48769996322073E-09 |
| Normal-vs-Female |
2.221800E-01 |
| Male-vs-Female |
4.03240000002025E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.375000E-04 |
| Normal-vs-Extreme_Weight |
5.19519982589145E-10 |
| Normal-vs-Obese |
5.72660000000003E-05 |
| Normal-vs-Extreme_Obese |
1.612080E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.479800E-02 |
| Normal_Weight-vs-Obese |
8.835000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.230000E-01 |
| Extreme_Weight-vs-Obese |
4.731600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.050400E-01 |
| Obese-vs-Extreme_Obese |
4.218000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.104000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.55071999999867E-05 |
| Normal-vs-Age(61-80Yrs) |
2.75289999684958E-08 |
| Normal-vs-Age(81-100Yrs) |
3.01160000004685E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.199800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.424160E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.309900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.239840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.404040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.693000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.37900000307667E-08 |
| Normal-VS-Type2 PRCC |
4.04609999999916E-05 |
| Normal-VS-KIRP CIMP |
5.423200E-01 |
| Normal-VS-Unclassified PRCC |
1.896870E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.915200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.295500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.007500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.183100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.432200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.948000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01420000070607E-09 |
| Normal-vs-N1 |
9.719900E-02 |
| Normal-vs-N2 |
8.509800E-01 |
| N0-vs-N1 |
4.084500E-02 |
| N0-vs-N2 |
3.045900E-02 |
| N1-vs-N2 |
6.189200E-01 |
|
|
